SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-001933
Filing Date
2024-01-04
Accepted
2024-01-04 08:08:04
Documents
14
Period of Report
2024-01-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d822244d8k.htm   iXBRL 8-K 28818
2 EX-99.1 d822244dex991.htm EX-99.1 24346
  Complete submission text file 0001193125-24-001933.txt   218419

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nams-20240104.xsd EX-101.SCH 3511
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nams-20240104_def.xml EX-101.DEF 13767
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nams-20240104_lab.xml EX-101.LAB 22448
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nams-20240104_pre.xml EX-101.PRE 14555
8 EXTRACTED XBRL INSTANCE DOCUMENT d822244d8k_htm.xml XML 5645
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 24509804
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)